<DOC>
	<DOC>NCT00636753</DOC>
	<brief_summary>The purpose of the study is to determine whether antipsychotic treatment is influence psychiatric patients due to endocrine and metabolic status and quality of life.</brief_summary>
	<brief_title>Antipsychotics and Metabolic Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Gender male Age 1845 Debut drugnaive schizophrenics, Caucasians Consent given to take part in the project Complianceproblems Major lung/kidney/hart/lever disorders Abuse of alcohol/drugs Diabetes 1 and 2 Antihypertensive Anticholesterolreducing medication Patients under duress</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Metabolic and endocrine changes in schizophrenic patients by antipsychotics treatment.</keyword>
</DOC>